Effectiveness and Safety of Firmagon in Androgen Ablative Therapy of Advanced Hormone-Dependent Prostate Carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 14 May 2014
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms FAST
- Sponsors Ferring Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 25 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004051).